Case Report SUCCESSFUL MANAGEMENT OF EALES DISEASE WITH TUBERCULAR ETIOLOGY

Main Article Content

Anindya Putri Kusumajati Mirza Metita

Abstract

Introduction: Recurrent vitreous hemorrhage is a defining indication of Eales disease, an idiopathic occlusive vasculitis of the peripheral retinal veins that primarily affects young males, and 38.7% of patients had a history of tuberculosis. This case study aims to illustrate the effective treatment of Eales disease, which includes vitreous hemorrhage and associated tuberculosis.


Case report: A 23-year-old male presented with the primary complaint of impaired vision in his left eye since two weeks ago. Visual acuity was 1/60, and ultrasonography revealed vitreous hemorrhage. The right eye also has a history of vitrectomy and silicon oil from a vitreous hemorrhage two months prior. A full work-up was completed, with positive interferon-gamma release assay (IGRA) results. The patient received a 6-month course of antituberculous medication and an oral steroid on a tapering dose. The vitrectomy procedure was conducted on the left eye, but vitreous hemorrhage persisted even after the surgery. Three months following surgery, the vitreous hemorrhage cleared, and the visual acuity improved to 6/6 with a negative IGRA result.


Discussion:Eales disease is identified in the condition of occlusive periphlebitis and retinal neovascularization, especially in the peripheral retina, in one or both eyes, after excluding other causes. Some patients may experience floaters, impaired vision, or even decreased visual acuity due to massive vitreous hemorrhage. In the earliest days of retinal perivasculitis, most patients are asymptomatic. Anti-tuberculosis treatment is considered for Eales disease with acute retinal periphlebitis with extensive infiltration, nodule development, and venous segment disappearance. In cases with persistent vitreous hemorrhage with decreased central vision for 3 months, vitrectomy is an option.


Conclusion: One of the features of Eales disease is a young adult with recurrent vitreous hemorrhage that is tuberculous in nature. Early identification and a thorough eye examination, including USG and IGRA testing, as well as appropriate medicinal and surgical care, will result in a positive outcome.

Keywords

Eales disease, vitreous haemorrhage, vitrectomy, tuberculous-related, retinavasculitis.

Article Details

How to Cite
KUSUMAJATI, Anindya Putri; METITA, Mirza. Case Report SUCCESSFUL MANAGEMENT OF EALES DISEASE WITH TUBERCULAR ETIOLOGY. International Journal of Retina, [S.l.], v. 7, n. 2, p. 161, sep. 2024. ISSN 2614-8536. Available at: <https://www.ijretina.com/index.php/ijretina/article/view/265>. Date accessed: 10 oct. 2024. doi: https://doi.org/10.35479/ijretina.2024.vol007.iss002.265.
Section
Case Report

References

1. Das T, Pathengay A, Hussain N, Biswas J. Eales’ disease: diagnosis and management. Eye. 2010 Mar;24(3):472–82.
2. Biswas J, Ravi RK, Naryanasamy A, Kulandai LT, Madhavan HN. Eales’ disease - current concepts in diagnosis and management. J Ophthalmic Inflamm Infect. 2013 Jan 14;3:11.
3. Ersöz MG, Hocaoğlu M, Sayman Muslubaş IB, Arf S, Karaçorlu M. Vitrectomy Due to Vitreous Hemorrhage and Tractional Retinal Detachment Secondary to Eales’ Disease. Turk J Ophthalmol. 2021 Apr;51(2):102–6.
4. Raizada K, Tripathy K. Eales Disease. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2023 Sep 22]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK559121/
5. Khan MN, Raza SS, Qadir S, Rehman H, Hussain AK, Nadeem MD, et al. Eales disease. Journal of Ayub Medical College Abbottabad. 2016;28(4):816–7.
6. Nicolcescu A, Mocanu C, Dinu L, Olaru A, Ionete M, Stefanescu DA. Unilateral Eales’ disease a case report. Rom J Ophthalmol. 2017;61(2):144–9.
7. Călugăru D, Călugăru M, El Ghali C. Eales disease in a young adult man Case report. Rom J Ophthalmol. 2017;61(4):306–9.
8. Rajpal, Singh U, Mohapatra S, Wagh V, Porwal C, Kaushik A. Association of mycobacterium tuberculosis in the causation of Eales’ disease: An institutional experience. Indian Journal of Medical Microbiology. 2015 Feb 1;33:S43–5.
9. Singh R, Toor P, Parchand S, Sharma K, Gupta V, Gupta A. Quantitative Polymerase Chain Reaction for Mycobacterium tuberculosis in So-called Eales’ Disease. Ocular Immunology and Inflammation. 2012 Jun 1;20(3):153–7.
10. Goel N, Kumar V, Arora S, Jain P, Ghosh B. Spectral domain optical coherence tomography evaluation of macular changes in Eales disease. Indian Journal of Ophthalmology. 2018 Mar;66(3):433.
11. CP J, AL G, JD L. Combination of Intravitreal Bevacizumab and Peripheral Photocoagulation: An Alternative Treatment in Eales Disease. Med Hypothesis Discov Innov Ophthalmol. 2013;2(2):30–4.
12. Biswas J, K.R R, Pal B, Gondhale HP, Kharel (Sitaula) R. Long-Term Outcomes of a Large Cohort of Patients with Eales’ Disease. Ocular Immunology and Inflammation [Internet]. 2018 Aug 18 [cited 2023 Sep 22]; Available from: https://www.tandfonline.com/doi/abs/10.1080/09273948.2017.1298817
13. El-Asrar AMA, Al-Kharashi SA. Full panretinal photocoagulation and early vitrectomy improve prognosis of retinal vasculitis associated with tuberculoprotein hypersensitivity (Eales’ disease). British Journal of Ophthalmology. 2002 Nov 1;86(11):1248–51.
14. Li J, Liu SM, Dong WT, Li F, Zhou CH, Xu XD, et al. Outcomes of transconjunctival sutureless 27-gauge vitrectomy for vitreoretinal diseases. qwer. 2018 Mar 13;11(3):408–15.
15. Saxena S. Eales’ Disease. In: Sheyman A, Fawzi AA, editors. Retinal Vascular Disease [Internet]. Singapore: Springer Nature; 2020 [cited 2023 Sep 22]. p. 77–83. (Retina Atlas). Available from: https://doi.org/10.1007/978-981-15-4075-2_8